Epidermal growth factor (EGF), a founding member of the EGF-family of proteins is a 6 kilodalton protein belonging to the EGF-protein family. EGF binds to the epidermal growth factor receptor (EGFR) and stimulates cell growth and differentiation . In humans, this protein is made of 53 amino acid residues and its tertiary structure is held together by 3 intramolecular disulfide bonds. Researchers first identified EGF in human urine and mice submaxillary glands as a secreted protein. Since then, EGF has been found in tears, saliva, milk, plasma, and tissues, including the parotid gland and submandibular gland-urogastrone or its trade name Heberprot-P.
EGF is a 6 kilodalton protein belonging to the EGF-protein family. EGF binds to the epidermal growth factor function and stimulates cell growth and differentiation. EGF was first discovered in human urine and mice submaxillary glands as a secreted protein. Since then, EGF has been found in tears, saliva, milk, plasma, and tissues, including the parotid gland and submandibular gland-urogastrone or its trade name Heberprot-P.
Our Epidermal growth factor (EGF) was the first growth factor to be discovered. EGF is identical to urogastrone (originally isolated from urine), which was shown to inhibit gastric acid secretion and promote healing of gastric ulcers. Specially formulated with 50% in powder form and 50% in liquid form for maximum release of ingredients, it is the perfect choice for anyone suffering from a pain caused by injury.
Fas ligand or FasL (CD178 or CD95L) is a homotrimeric human type II transmembrane protein. The Fas ligand gene (FASLG) on chromosome 1q24.3 encodes the Fas ligand protein. Cytotoxic T lymphocytes express FasL on their surfaces that belong to the TNF family of proteins. By binding to its receptors, FasL induces apoptosis in cells. A matrix metalloproteinase MMP-7 cleaves membrane-bound FasL and generates a soluble FasL. Fas ligand (CD178 or CD95L) is a type II transmembrane protein which is known to be homotrimeric. The Fas ligand protein is encoded by the Fas receptor gene (FASLG) on chromosome 1q24.3. Cytotoxic T lymphocytes express FasR on their surface that belongs to the TNF family of proteins. By binding with its receptors, FasR induces apoptosis in cells. A matrix metalloproteinase MMP-7 cleaves membrane-bound FasR and generates a soluble FasR.
Fas ligand elisa or CD95L is a homotrimeric protein that belongs to the tumor necrosis factor (TNF) family. FasL induces apoptosis in cells by binding to its receptor FasR. This interaction plays a crucial role in immune system regulation and cancer progression. A matrix metalloproteinase MMP-7 cleaves membrane bound FasL, generating a soluble FasL.
Fas ligand (FasL) is a cell surface protein belonging to the tumor necrosis factor family of proteins. The bioactive FasL protein can be generated by proteolytic cleavage of the membrane bound form and is then referred to as soluble Fas ligand (sFasL). Both forms of FasL bind to the death receptor that is expressed on the surface of many cell types. Binding of FasL to its receptor induces apoptosis in transfected mammalian cells and target cells activated by mitogens. A number of studies have shown that its expression is elevated in leukemias, lymphomas, pancreatic tumors and a wide range of other human cancers. Recently, it has been shown that sFasL levels are elevated in sera from patients with rheumatoid arthritis, alcoholic hepatitis and autoimmune chronic active hepatitis.
